amyloid-beta-42 peptide in saliva

Indications

• proposed as a screening test for Alzheimer's disease Referennce interval:
• < 20 pg/mL

Clinical significance

• levels of 40-85 pg/mL may be associated with deposition of amyloid in the brain

More general terms

• amyloid-beta peptide in saliva

Additional terms

• A4 amyloid peptide; beta-peptide